This disclosure provides a robust sensitive and specific assay for the detection and measurement of DPP 4 levels in samples obtained from human patients. The disclosure further provides novel anti DPP 4 monoclonal antibodies that recognize human DPP 4 and assay kits comprising one or more of these antibodies.